Thyroid cancer
The past 5–10 years have brought in a new era in the care of patients with thyroid cancer,
with the introduction of transformative diagnostic and management options. Several …
with the introduction of transformative diagnostic and management options. Several …
Anaplastic thyroid carcinoma: an update
Simple Summary Anaplastic thyroid carcinoma (ATC) has a dismal prognostic.
Chemotherapy and radiotherapy are the mainstem options for patients with ATC. In selected …
Chemotherapy and radiotherapy are the mainstem options for patients with ATC. In selected …
[HTML][HTML] Dabrafenib plus trametinib in patients with BRAF V600E-mutant anaplastic thyroid cancer: updated analysis from the phase II ROAR basket study
V Subbiah, RJ Kreitman, ZA Wainberg, JY Cho… - Annals of …, 2022 - Elsevier
Background Combined therapy with dabrafenib plus trametinib was approved in several
countries for treatment of BRAF V600E-mutant anaplastic thyroid cancer (ATC) based on an …
countries for treatment of BRAF V600E-mutant anaplastic thyroid cancer (ATC) based on an …
[HTML][HTML] Molecular diagnosis and targeted treatment of advanced follicular cell-derived thyroid cancer in the precision medicine era
J Capdevila, A Awada, D Führer-Sakel… - Cancer Treatment …, 2022 - Elsevier
Most malignant thyroid tumours are initially treated with surgery or a combination of surgery
and radioactive iodine (RAI) therapy. However, in patients with metastatic disease, many …
and radioactive iodine (RAI) therapy. However, in patients with metastatic disease, many …
Anaplastic thyroid cancer: new horizons and challenges
A Maniakas, M Zafereo… - … and Metabolism Clinics, 2022 - endo.theclinics.com
Anaplastic Thyroid Cancer - Endocrinology and Metabolism Clinics Skip to Main Content
Advertisement Endocrinology and Metabolism Clinics Log in Register Log in Subscribe Claim …
Advertisement Endocrinology and Metabolism Clinics Log in Register Log in Subscribe Claim …
[HTML][HTML] Molecular basis and targeted therapy in thyroid cancer: Progress and opportunities
L Zhang, Q Feng, J Wang, Z Tan, Q Li, M Ge - Biochimica et Biophysica …, 2023 - Elsevier
Thyroid cancer (TC) is the most prevalent endocrine malignant tumor. Surgery,
chemotherapy, radiotherapy, and radioactive iodine (RAI) therapy are the standard TC …
chemotherapy, radiotherapy, and radioactive iodine (RAI) therapy are the standard TC …
Anaplastic thyroid cancer: An update
SN Rao, RC Smallridge - Best Practice & Research Clinical Endocrinology …, 2023 - Elsevier
Anaplastic thyroid cancer (ATC) is one of the most lethal of all cancers. It is more common in
women and occurs primarily in older patients. ATC has a median overall survival of 3–5 …
women and occurs primarily in older patients. ATC has a median overall survival of 3–5 …
Combination targeted therapy with pembrolizumab and lenvatinib in progressive, radioiodine-refractory differentiated thyroid cancers
JD French, BR Haugen, FP Worden… - Clinical Cancer …, 2024 - aacrjournals.org
Purpose: Lenvatinib, a potent multikinase inhibitor, improves progression-free survival (PFS)
in patients with radioiodine (RAI)-refractory differentiated thyroid cancer; however, most …
in patients with radioiodine (RAI)-refractory differentiated thyroid cancer; however, most …
Peptide receptor radionuclide therapy in thyroid cancer
The treatment options that are currently available for management of metastatic, progressive
radioactive iodine (RAI)-refractory differentiated thyroid cancers (DTCs), and medullary …
radioactive iodine (RAI)-refractory differentiated thyroid cancers (DTCs), and medullary …
Translating the immune microenvironment of thyroid cancer into clinical practice
Thyroid cancer is an excellent model for studying tumor immune microenvironment, as it
often shows local signs of an immune response. The tumor immune microenvironment of …
often shows local signs of an immune response. The tumor immune microenvironment of …